Caribou Biosciences Inc.

NASDAQ: CRBU · Real-Time Price · USD
0.93
0.09 (10.73%)
At close: May 16, 2025, 3:59 PM
0.90
-3.24%
Pre-market: May 19, 2025, 07:00 AM EDT

Caribou Biosciences Revenue Breakdown

Period Ending Dec 31, 2024
Reportable Segment Revenue 9.99M
Reportable Segment Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 9.73M 10.49M 9.84M 10.63M 14.64M 7.75M 9.71M 10.12M 8.91M 8.53M 9.85M 10.04M 9.59M 7.85M 6.76M 5.11M 4.6M 4.17M 3.25M 3.15M 3.49M
Selling, General, and Administrative Revenue Growth -7.18% +6.57% -7.41% -27.41% +89.02% -20.22% -4.04% +13.59% +4.39% -13.35% -1.94% +4.70% +22.16% +16.17% +32.21% +11.25% +10.14% +28.52% +2.98% -9.63% n/a
Research and Development Revenue 35.53M 30.46M 30.42M 35.48M 33.79M 31.28M 28.58M 26.5M 25.71M 25.74M 19.99M 22.58M 13.92M 15.11M 15.83M 12.33M 10.16M 12.02M 6.18M 7.58M 8.64M
Research and Development Revenue Growth +16.63% +0.14% -14.26% +5.01% +8.02% +9.43% +7.85% +3.09% -0.10% +28.74% -11.46% +62.16% -7.86% -4.56% +28.44% +21.27% -15.46% +94.56% -18.47% -12.28% n/a